{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:06:07Z","timestamp":1793653567514,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.rbmo.2019.11.006","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T20:13:53Z","timestamp":1574972033000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-3370","authenticated-orcid":false,"given":"Alexander","family":"Volodarsky-Perel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Togas","family":"Tulandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weon-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-6144","authenticated-orcid":false,"given":"Eva","family":"Suarthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Buckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.11.006_bib0001","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"Reprod. Biomed. Online."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2012.06.007","article-title":"Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation","volume":"98","author":"Almog","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0003","first-page":"2051","article-title":"Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response","volume":"33","author":"Alvarez","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0004","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5858\/134.3.326","article-title":"The 2009 version of the cancer protocols of the college of american pathologists","volume":"134","author":"Amin","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/humrep\/dey216","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0006","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12885-018-4682-1","article-title":"Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study","volume":"18","author":"Baeyens-Fernandez","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0007","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0008","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","article-title":"Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience","volume":"32","author":"Cardozo","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0009","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.fertnstert.2008.04.014","article-title":"Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes","volume":"91","author":"Chian","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-017-4288-3","article-title":"Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy","volume":"165","author":"Chien","year":"2017","journal-title":"Breast. Cancer. Res. Treat."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2016.09.041","article-title":"Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment","volume":"107","author":"Creux","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0012","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201018666170808122531","article-title":"Random start ovarian stimulation for oocyte and embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy","volume":"18","author":"Danis","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rbmo.2018.01.016","article-title":"Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls","volume":"36","author":"Decanter","year":"2018","journal-title":"Reprod. Biomed. Online."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0014","first-page":"439","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer. J. Clin."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","author":"Domingo","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0016","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0017","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0018","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.fertnstert.2003.07.027","article-title":"Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients","volume":"81","author":"Escudero","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0019","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.05.034","article-title":"Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion","volume":"110","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","article-title":"Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study","volume":"18","author":"Fidler","year":"2017","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","article-title":"Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis","volume":"97","author":"Friedler","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0022","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0974-1208.112377","article-title":"Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction","volume":"6","author":"Himabindu","year":"2013","journal-title":"J. Hum. Reprod. Sci."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0024","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/bies.10155","article-title":"Defining the actions of transforming growth factor beta in reproduction","volume":"24","author":"Ingman","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/PPO.0000000000000344","article-title":"Oncofertility: meeting the fertility goals of adolescents and young adults with cancer","volume":"24","author":"Irene Su","year":"2018","journal-title":"Cancer. J."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000459","article-title":"Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists","volume":"4","author":"Kitano","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2009.03.028","article-title":"Fertility preservation for female cancer patients: early clinical experience","volume":"94","author":"Klock","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.rbmo.2018.04.047","article-title":"Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type","volume":"37","author":"Lefebvre","year":"2018","journal-title":"Reprod. Biomed. Online."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0029","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/humrep\/dex276","article-title":"Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer","volume":"32","author":"Letourneau","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0030","article-title":"Effects of malignancies on fertility preservation outcomes and relevant cryobiological advances","author":"Liu","year":"2019","journal-title":"Sci. China. Life. Sci"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0031","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/humrep\/dex218","article-title":"Update on fertility preservation from the Barcelona International Society for Fertility Preservation \u2013 ESHRE \u2013 ASRM 2015 meeting: indications, results, and future perspectives","volume":"32","author":"Martinez","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0032","first-page":"91","article-title":"Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients","volume":"23","author":"Moraes","year":"2019","journal-title":"JBRA Assist. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0033","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.fertnstert.2010.12.041","article-title":"Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment","volume":"95","author":"Moria","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0034","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3332\/ecancer.2015.504","article-title":"Ovarian stimulation in patients with breast cancer","volume":"9","author":"Munoz","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0035","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"10","author":"Oktay","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0036","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0037","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0038","first-page":"568","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0039","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/gme.0b013e3181f8d9e0","article-title":"Changes in serum antim\u00fcllerian hormone levels across the ovulatory menstrual cycle in late reproductive age","volume":"18","author":"Robertson","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.rbmo.2019.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: treat the tumour and treat the host","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0041","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/des260","article-title":"Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability","volume":"27","author":"Rustamov","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0042","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0043","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GCO.0000000000000170","article-title":"Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin","volume":"27","author":"Thomsen","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0044","first-page":"e12797","article-title":"Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: a retrospective cohort of 157 patients","volume":"27","author":"Tsampras","year":"2018","journal-title":"Eur. J. Cancer. Care."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/humrep\/dey382","article-title":"Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response","volume":"34","author":"Volodarsky-Perel","year":"2019","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.11.006_bib0046","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10815-018-1227-0","article-title":"Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations","volume":"35","author":"von Wolff","year":"2018","journal-title":"J. Assist. Reprod. Genet."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319308302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319308302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:17:04Z","timestamp":1761466624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319308302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1472648319308302"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.11.006","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}